Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
Bioventus (Nasdaq:BVS) announced that Senior Vice-President and CFO Mark Singleton will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 4:00 p.m. ET.
Rhea-AI Summary
Bioventus (Nasdaq:BVS) announced that Senior Vice-President and CFO Mark Singleton will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 4:00 p.m. ET.
A live webcast and replay will be available in the Investors section of the Bioventus website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BVS
On Jun 2, the day this news came out, BVS closed 2.27% above the previous close.
Data tracked by StockTitan Argus for the Jun 2 session.
Key Figures
- Conference edition
- 47th Annual
- Goldman Sachs Global Healthcare Conference
- Conference date
- June 8, 2026
- Scheduled Bioventus fireside chat
- Presentation time
- 4:00 p.m. ET
- Start time of fireside chat webcast
Historical Context
-
Q1 2026 results with revenue growth and raised EPS and cash guidance.
-
Announcement of date and webcast details for Q1 2026 earnings call.
-
Q4 and full-year 2025 results with adjusted EBITDA growth and 2026 guidance.
-
Notification of Q4 2025 earnings release date and investor call logistics.
-
CEO presentation at J.P. Morgan Healthcare Conference with webcast and replay.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026, at 4:00 p.m. ET.
A live webcast of the presentation will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.